Reviewed by Vass Vassiliou
Mobile health (mHealth) technologies offer significant promise for the prevention of heart failure (HF) in clinical practice. Through remote monitoring, digital coaching, wearable sensors, and predictive analytics, mHealth tools can support early risk identification, improve management of hypertension and diabetes, enhance medication adherence, and promote lifestyle modification. Despite this potential, widespread and sustainable implementation in routine care remains limited. Multiple barriers—spanning patient, clinician, organizational, technological, regulatory, and research domains—constrain effective integration. In this issue of European Journal of Preventive Cardiology, Toshiki Kaihara illustrates barriers which manifest differently across healthcare systems, particularly when comparing Europe and Asia in the implementation of digital health in primary prevention [1].
At the patient level, digital literacy remains a central challenge. Individuals at highest risk for HF are often older adults, who may have limited familiarity with smartphones, apps, or wearable technologies. Even when access is available, complex interfaces and poorly designed user experiences reduce engagement and long-term adherence. Cognitive impairment, visual limitations, and multimorbidity further complicate consistent use. Socioeconomic disparities also contribute to inequitable implementation. Reliable internet access, smartphones, and wearable devices are not universally available, particularly in rural or low-income populations. Lower health literacy may impair understanding of app-based recommendations, while language and cultural mismatches reduce inclusivity. Sustained engagement is another concern, as many users discontinue health apps within months due to alert fatigue, perceived burden of daily data entry, or lack of perceived benefit. Privacy concerns and uncertainty about how personal health data are stored, shared, and protected can further limit trust and adoption [2].
Clinician-level barriers are equally significant. One of the most frequently cited challenges is workflow disruption. Patient-generated data from wearables and apps often do not integrate seamlessly into electronic health records (EHRs), requiring clinicians to log into separate platforms. The volume of incoming data can be overwhelming, contributing to alert fatigue and increased administrative workload. Without clear clinical protocols defining when and how to respond to abnormal values, clinicians may hesitate to rely on mHealth inputs. Concerns about data accuracy and clinical validity also persist. Wearable sensors may show variability in measurements such as heart rate, blood pressure, or weight. Moreover, although evidence supporting remote monitoring in established HF management is growing, high-quality randomized trials focused specifically on primary prevention remain limited. Reimbursement structures add another layer of difficulty, as compensation for remote monitoring services is inconsistent, reducing incentives for preventive digital care.
At the health system and organizational level, interoperability presents a major obstacle. Many mHealth applications operate in proprietary ecosystems and lack standardized data formats, limiting integration with existing EHR infrastructure. This fragmentation hampers scalability and coordinated care. Upfront implementation costs—including infrastructure development, device procurement, cybersecurity safeguards, staff training, and ongoing technical support—can be substantial. Health systems may be reluctant to invest without clear evidence of cost-effectiveness or return on investment. Legal and regulatory uncertainties also create hesitation. Oversight by agencies such as the U.S. Food and Drug Administration continues to evolve, particularly regarding software as a medical device and AI-based risk prediction tools. Liability concerns arise when clinicians receive real-time remote data but fail to act, or when false alerts prompt unnecessary interventions. Compliance with data protection regulations, including the Health Insurance Portability and Accountability Act (HIPAA), adds additional administrative complexity.
Technology-specific barriers further complicate implementation. Without explainable outputs, integrating AI-driven risk scores into shared decision-making becomes difficult. Scalability is another concern; interventions that perform well in controlled pilot studies often struggle when deployed across diverse populations with varying socioeconomic and clinical characteristics.
Evidence gaps remain a critical limitation. Much of the existing mHealth literature focuses on secondary prevention or disease management in patients with established HF, rather than primary prevention in high-risk populations. Furthermore, many studies are conducted in high-income settings with technologically engaged participants, reducing generalizability to rural, underserved, or digitally marginalized communities. Stronger pragmatic trials embedded within real-world clinical systems are needed to demonstrate effectiveness, cost-efficiency, and equity.
Policy-level challenges intersect with these issues. Reimbursement policies for remote patient monitoring vary, for example under programs administered by the Centres for Medicare & Medicaid Services in the United States. Inconsistent coverage discourages systematic adoption. Professional guidelines are also still evolving. Organizations such as the American Heart Association and the European Society of Cardiology increasingly acknowledge digital health, yet standardized recommendations for mHealth use in HF prevention remain limited. Without clear guidance, implementation depends largely on local enthusiasm and resources rather than structured policy frameworks [3].
In summary, while mHealth technologies offer transformative potential for heart failure prevention, their translation into routine clinical practice is constrained by interconnected barriers at patient, clinician, organizational, technological, evidence, and policy levels. Addressing these challenges requires user-centred design, seamless EHR integration, robust data governance, transparent algorithms, equitable access strategies, clear reimbursement models, and high-quality long-term evidence. Only through coordinated efforts across stakeholders can mHealth fulfil its promise in reducing the growing global burden of heart failure.
